Innate Immunotherapeutics completes $9mn IPO

Singapore: Innate Immunotherapeutics has raised $8.9 million (AUD10 million) through its Initial Public Offer (IPO) that...

December 18, 2013 | Wednesday | News
BioDiem gets hepatitis vaccine tech from Canberra univ

Singapore: Australian infectious disease therapy and vaccine development company BioDiem has signed an agreement to lice...

June 29, 2012 | Friday | News
Infect mosquitoes with Wolbachia, stop diseases

Singapore: Scientists at Melbourne University and University of California have found that mosquito that are infected wi...

April 11, 2013 | Thursday | News
NZ gets drug that glows brain tumour

Singapore: A novel drug, GLIOLAN (aminolevulinic acid HCl), that helps neurosurgeons to better visualise and remove mali...

September 21, 2015 | Monday | News
Australia's Alchemia announces sale of Fondaparinux IP

Singapore: Alchemia, an Australian drug discovery and development company, has announced that it has entered into a bind...

September 28, 2015 | Monday | News
UBI quarterly service fees increase by 311%

Singapore: Medical diagnostics company Universal Biosensors (UBI) published its quarterly cash flow report for the quart...

January 25, 2013 | Friday | Company results
Mayne pharma to expand its Greenville facility; add 110 jobs

Singapore: Australia-based specialty pharmaceutical company, Mayne pharma, recently announced plans to invest $65 millio...

August 28, 2015 | Friday | News
LBT Innovations inks partnership with French tech firm

Singapore: Australian medical technology company, LBT Innovations, has signed a license agreement with French in vitro d...

August 27, 2015 | Thursday | News
Garvan Institute develops first-ever biologically stable antibodies

Singapore: One of the most challenging tasks ahead of pharmaceutical companies is to create antibodies that are stable e...

October 3, 2012 | Wednesday | News
Future of Healthcare in Asia

Healthcare industry is in a period of evolution accelerated by changing demographics and market forces propelled by insu...

May 5, 2014 | Monday | Analysis
Phylogica appoints CEO, CSO, CFO

Singapore: Leading Australian peptide drug discovery company Phylogica appointed Dr Richard Hopkins as the company's new...

July 23, 2013 | Tuesday | News
New South Wales govt launches Medical Devices Fund

Singapore: The New South Wales (NSW) Government in Australia has established a Medical Devices Fund under which it will ...

September 4, 2012 | Tuesday | News
Anteo Diagnostic to enter Korea market

Singapore: Australia based global medical technology company, Anteo Diagnostics, has entered into a non-exclusive distri...

October 20, 2015 | Tuesday | News
Australia's Anteo Diagnostics to acquire Belgium Dx firm

Singapore: Australia based Anteo Diagnostics has decided to acquire DIAsource ImmunoAssays, (DIAsource), a global specia...

August 27, 2015 | Thursday | News
Hatchtech gets patent for head lice cure, DeOvo

Singapore: Australia-based specialty pharmaceutical company, Hatchtech, has been granted a patent by the US Patent and T...

July 25, 2012 | Wednesday | News
Challenge No 5: Talent trouble

Lack of trained and skilled workforce, identifying a market-savvy work force and retaining the right people on key posit...

May 17, 2012 | Thursday | Analysis
Funding uncertainty hinders Australian life science

Singapore: A prominent healthcare industry leader sounded the alarm over Australia's system for approving government fun...

October 9, 2012 | Tuesday | News
Sunshine Heart appoints Jon W Salveson to board

Singapore: Sunshine Heart, a medical devices company listed on Nasdaq and ASX, has appointed that Mr Jon W Salveson to t...

March 20, 2013 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls